6-fluorometaraminol has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallagher, K; Guibourg, H; Hutchins, G; McClanahan, T; Rosenspire, K; Schwaiger, M; Wieland, DM | 1 |
1 other study(ies) available for 6-fluorometaraminol and Coronary Disease
| Article | Year |
|---|---|
Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol.
Topics: Animals; Coronary Disease; Dogs; Female; Fluorine Radioisotopes; Heart; Male; Metaraminol; Radionuclide Imaging; Sympathetic Nervous System | 1990 |